Cardiovascular risk prediction in healthy older people.
Cardiovascular risk prediction in healthy older people.
复制标题
DOI:
10.1007/s11357-021-00486-z
复制
发表时间:
2022-03
期刊:
影响因子:
5.6
通讯作者:
McNeil JJ
中科院分区:
文献类型:
--
作者:
Neumann JT;Thao LTP;Callander E;Chowdhury E;Williamson JD;Nelson MR;Donnan G;Woods RL;Reid CM;Poppe KK;Jackson R;Tonkin AM;McNeil JJ
Identification of individuals with increased risk of major adverse cardiovascular events (MACE) is important. However, algorithms specific to the elderly are lacking. Data were analysed from a randomised trial involving 18,548 participants ≥ 70 years old (mean age 75.4 years), without prior cardiovascular disease events, dementia or physical disability. MACE included coronary heart disease death, fatal or nonfatal ischaemic stroke or myocardial infarction. Potential predictors tested were based on prior evidence and using a machine-learning approach. Cox regression analyses were used to calculate 5-year predicted risk, and discrimination evaluated from receiver operating characteristic curves. Calibration was also assessed, and the findings internally validated using bootstrapping. External validation was performed in 25,138 healthy, elderly individuals in the primary care environment. During median follow-up of 4.7 years, 594 MACE occurred. Predictors in the final model included age, sex, smoking, systolic blood pressure, high-density lipoprotein cholesterol (HDL-c), non-HDL-c, serum creatinine, diabetes and intake of antihypertensive agents. With variable selection based on machine-learning, age, sex and creatinine were the most important predictors. The final model resulted in an area under the curve (AUC) of 68.1 (95% confidence intervals 65.9; 70.4). The model had an AUC of 67.5 in internal and 64.2 in external validation. The model rank-ordered risk well but underestimated absolute risk in the external validation cohort. A model predicting incident MACE in healthy, elderly individuals includes well-recognised, potentially reversible risk factors and notably, renal function. Calibration would be necessary when used in other populations. The online version contains supplementary material available at 10.1007/s11357-021-00486-z.
登录
查看更多内容
DOI:
10.1056/nejmoa1805819
发表时间:
2018-10-18
期刊:
The New England journal of medicine
影响因子:
--
作者:
McNeil JJ;Wolfe R;Woods RL;Tonkin AM;Donnan GA;Nelson MR;Reid CM;Lockery JE;Kirpach B;Storey E;Shah RC;Williamson JD;Margolis KL;Ernst ME;Abhayaratna WP;Stocks N;Fitzgerald SM;Orchard SG;Trevaks RE;Beilin LJ;Johnston CI;Ryan J;Radziszewska B;Jelinek M;Malik M;Eaton CB;Brauer D;Cloud G;Wood EM;Mahady SE;Satterfield S;Grimm R;Murray AM;ASPREE Investigator Group
通讯作者:
ASPREE Investigator Group
DOI:
10.1016/s0140-6736(20)32332-1
发表时间:
2020-11-21
期刊:
Lancet (London, England)
影响因子:
--
作者:
Gencer B;Marston NA;Im K;Cannon CP;Sever P;Keech A;Braunwald E;Giugliano RP;Sabatine MS
通讯作者:
Sabatine MS
影响因子:
168.9
作者:
Bloom, David E.;Chatterji, Somnath;Kowal, Paul;Lloyd-Sherlock, Peter;Mckee, Martin;Rechel, Bernd;Rosenberg, Larry;Smith, James P.
通讯作者:
Smith, James P.
影响因子:
6.3
作者:
Dalton, Jarrod E.;Rothberg, Michael B.;Perzynski, Adam T.
通讯作者:
Perzynski, Adam T.
影响因子:
3.5
作者:
Schofield, Deborah;Kelly, Simon;Percival, Richard
通讯作者:
Percival, Richard